Artelo Biosciences Files 8-K on Security Holder Votes
Ticker: ARTL · Form: 8-K · Filed: Dec 20, 2024 · CIK: 1621221
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: ARTL
TL;DR
ARTL shareholders voted on something important, filing is light on details.
AI Summary
Artelo Biosciences, Inc. filed an 8-K on December 20, 2024, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about the votes or outcomes, but it serves as an official notification of these events.
Why It Matters
This filing indicates that Artelo Biosciences held a vote of its shareholders, which could pertain to significant corporate actions or governance changes.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose new financial information or significant operational changes that would immediately impact risk.
Key Players & Entities
- ARTELO BIOSCIENCES, INC. (company) — Registrant
- December 20, 2024 (date) — Date of Report
- Nevada (jurisdiction) — State of Incorporation
- 505 Lomas Santa Fe, Suite 160 (address) — Principal Executive Offices
- Solana Beach, CA (location) — City, State of Principal Executive Offices
FAQ
What specific matters were submitted to a vote of Artelo Biosciences' security holders?
The filing states that matters were submitted to a vote of security holders, but does not specify the exact proposals or resolutions presented.
When did the events related to the security holder vote occur?
The earliest event reported in this 8-K filing is dated December 20, 2024.
What is the primary purpose of this 8-K filing?
The primary purpose is to report on the submission of matters to a vote of security holders, as required by SEC regulations.
Does this filing provide details on the outcome of the security holder vote?
No, this filing indicates that matters were submitted to a vote but does not disclose the results or outcomes of that vote.
What is Artelo Biosciences, Inc.'s state of incorporation?
Artelo Biosciences, Inc. is incorporated in Nevada.
Filing Stats: 553 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-12-20 16:45:14
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share ARTL The Nasdaq Stock Mar
Filing Documents
- artl_8k.htm (8-K) — 29KB
- 0001640334-24-001915.txt ( ) — 152KB
- artl-20241220.xsd (EX-101.SCH) — 6KB
- artl-20241220_lab.xml (EX-101.LAB) — 15KB
- artl-20241220_cal.xml (EX-101.CAL) — 1KB
- artl-20241220_pre.xml (EX-101.PRE) — 9KB
- artl-20241220_def.xml (EX-101.DEF) — 2KB
- artl_8k_htm.xml (XML) — 4KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. We held our Annual Meeting of Stockholders ("Annual Meeting") on December 20, 2024. Of the 3,227,700 shares of our common stock outstanding and entitled to vote as of December 4, 2024, 1,319,986 or 40.9% of such shares were represented, either by attending the Annual Meeting or by proxy, constituting a quorum under our bylaws. The matters voted on at the Annual Meeting and the votes cast with respect to each such matter are set forth below. 1. Election of Directors . The following nominees were re-elected by the holders of our common stock to serve as directors to hold office until our 2027 annual meeting of stockholders and until their successors have been duly elected and qualified: Class I Nominees Nominee For Against Abstain Broker Non Vote Steven Kelly 442,956 64,966 11,497 800,567 R. Martin Emanuele, Ph.D. 461,960 45,962 11,497 800,567 2. Ratification of Appointment of Independent Registered Public Accounting Firm. The appointment of Malone Bailey LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified based on the following results of voting: For Against Abstain 1,258,378 57,083 4,525 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ARTELO BIOSCIENCES, INC. /s/ Gregory D. Gorgas Gregory D. Gorgas President & Chief Executive Officer Date: December 20, 2024 3